PharmaLex Group, one of the most experienced and successful specialist providers of Development Consulting, Regulatory Affairs, Pharmacovigilance, Epidemiology & Risk Management, and Quality Management & Compliance worldwide, has completed the merger with CompliMed in the United Kingdom.
CompliMed is the UK’s leading Healthcare Compliance Consultancy specialising in the ABPI Code of Practice. Their services include training, e-learning, outsourcing, audits, SOPs, medical review and final signatory support.
“CompliMed is a perfect fit for PharmaLex” explained Dr Thomas Dobmeyer, CEO PharmaLex. “Our strategy is to build a European service line that offers healthcare compliance in all European countries and the US. CompliMed is trusted by its customers for its high-quality standards. Having such a dependable team join PharmaLex is a real asset as both organisations are committed to outstanding service levels and delivering exceptional client solutions”, he added.
Rina Newton, (Managing Director, CompliMed) commented: "Andy and Charlie at WKCF worked tirelessly on this merger to provide an outstanding level of service. Notably, their extensive experience shone through during a complex due diligence process, where I relied on their expert insight and clear advice to achieve the best possible outcome. They are THE team I needed by my side and I would not hesitate in recommending them to anyone considering a sale, acquisition or merger."
Andy Coghlan, (Partner, WK Corporate Finance) commented: "We are delighted to have advised Rina and the CompliMed team on their merger with PharmaLex. This transaction highlights WKCF's ability to source global strategic partners for our clients, as well as building on our growing Pharma services experience".